Track the JOINN Laboratories (China) Co., Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, JOINN Laboratories (China) Co., Ltd. has published 6 reports. Market capitalisation: €18.3bn. The latest transaction was reported on 7 May 2026 (Purchase). Among the most active insiders: Feng Yuxia. All data is openly available.
Analysts rate JOINN Laboratories (China) Co., Ltd. Buy (bullish), based on 5 analysts. Average price target: HK$22.74.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
JOINN Laboratories (China) Co., Ltd. 是一家专注于药物研发以及临床前和临床测试服务的公司。该公司在香港证券交易所上市。